MAMLD1
Mastermind-like domain-containing protein 1
Also known as: CG1, CXorf6, F18, MAMD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13495
- Gene
- MAMLD1
- Ensembl
- ENSG00000013619
- Chromosome
- X
- Canonical length
- 774 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a mastermind-like domain containing protein. This protein may function as a transcriptional co-activator. Mutations in this gene are the cause of X-linked hypospadias type 2. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]
Canonical amino-acid sequenceUniProt
774 residues, UniProt reviewed canonical sequence.
>Q13495|MAMLD1
1 MDDWKSRLVI KSMLPHFAMV GNRQEPRKLQ ESGKKPSWME EEDLSFLYKS SPGRKHQGTV
61 KRRQEEDHFQ FPDMADGGYP NKIKRPCLED VTLAMGPGAH PSTACAELQV PPLTINPSPA
121 AMGVAGQSLL LENNPMNGNI MGSPFVVPQT TEVGLKGPTV PYYEKINSVP AVDQELQELL
181 EELTKIQDPS PNELDLEKIL GTKPEEPLVL DHPQATLSTT PKPSVQMSHL ESLASSKEFA
241 SSCSQVTGMS LQIPSSSTGI SYSIPSTSKQ IVSPSSSMAQ SKSQVQAMLP VALPPLPVPQ
301 WHHAHQLKAL AASKQGSATK QQGPTPSWSG LPPPGLSPPY RPVPSPHPPP LPLPPPPPPF
361 SPQSLMVSCM SSNTLSGSTL RGSPNALLSS MTSSSNAALG PAMPYAPEKL PSPALTQQPQ
421 FGPQSSILAN LMSSTIKTPQ GHLMSALPAS NPGPSPPYRP EKLSSPGLPQ QSFTPQCSLI
481 RSLTPTSNLL SQQQQQQQQQ QQANVIFKPI SSNSSKTLSM IMQQGMASSS PGATEPFTFG
541 NTKPLSHFVS EPGPQKMPSM PTTSRQPSLL HYLQQPTPTQ ASSATASSTA TATLQLQQQQ
601 QQQQQQPDHS SFLLQQMMQQ PQRFQRSVAS DSMPALPRQG CCHLFAWTSA ASSVKPQHQH
661 GNSFTSRQDP QPGDVSPSNI THVDKACKLG EARHPQVSLG RQPPSCQALG SESFLPGSSF
721 AHELARVTSS YSTSEAAPWG SWDPKAWRQV PAPLLPSCDA TARGTEIRSY GNDPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAMLD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.71
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- ovary: 11 nTPM
- testis: 8.2 nTPM
- cerebral cortex: 5.9 nTPM
- seminal vesicle: 5.8 nTPM
- endometrium: 4.8 nTPM
- hypothalamus: 4.7 nTPM
Single-cell type
- sertoli cells: 371 nCPM
- leydig cells: 194 nCPM
- oligodendrocyte progenitor cells: 143 nCPM
- monocytes: 117 nCPM
- cone photoreceptor cells: 110 nCPM
- gonadotrophs: 110 nCPM
Immune cell
- memory B-cell: 0.7 nTPM
- naive CD8 T-cell: 0.7 nTPM
- T-reg: 0.5 nTPM
- memory CD4 T-cell: 0.4 nTPM
- MAIT T-cell: 0.3 nTPM
- memory CD8 T-cell: 0.3 nTPM
Brain region
- hypothalamus: 35 nTPM
- basal ganglia: 25 nTPM
- cerebral cortex: 24 nTPM
- amygdala: 23 nTPM
- hippocampal formation: 22 nTPM
- pons: 22 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MAMLD1.
Disease | AllUniProt
Conditions MAMLD1 is implicated in, by any mechanism.
- Hypospadias 2, X-linked (HYSP2) MIM:300758
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 282 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hypospadias 2, X-linked
- 46,XY ovotesticular disorder of sex development
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.63
- gnomAD missense Z
- 0.6
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Mastermind-like domain-containing protein 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAMLD1 as an antibody target. Whether an autoantibody or antibody against MAMLD1 could matter depends on whether native MAMLD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAMLD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAMLD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...